Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
暂无分享,去创建一个
William F. Fadel | S. E. Reese | C. Mcevoy | R. Link-Gelles | S. Schrag | P. Embí | K. Natarajan | S. Grannis | Alexandra F. Dalton | E. Azziz-Baumgartner | B. Fireman | A. Naleway | M. Gaglani | M. Thompson | J. Verani | Toan C Ong | Patrick K. Mitchell | K. Murthy | B. Dixon | N. Klein | Stephanie A. Irving | M. DeSilva | N. Lewis | L. Blanton | J. Ferdinands | Sue B. Reynolds | E. Stenehjem | Mehiret H. Wondimu | Eric P. Griggs | K. Goddard | O. Zerbo | Alexandra F Dalton | A. Kharbanda | W. Fadel | K. Dascomb | Catherine H Bozio | M. Barron | Jungmi Han | Kristin Goddard | Jeremiah Williams | E. Griggs | S. Reese | Monica Dickerson | Deepika Konatham | S. Rao | P. Patel | I-Chia Liao | N. Grisel | Duck-Hye Yang | Julie Arndorfer | S. Irving | S. Reynolds | J. Arndorfer | N. Valvi | M. Dickerson | R. Birch | D. Konatham | Ousseny Zerbo | Nimish Valvi | Kempapura Murthy | E. Azziz‐Baumgartner